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Nucleotide	   signaling	   molecules	   contribute	   to	   the	   regulation	   of	   cellular	  
pathways	  in	  all	  forms	  of	  life.	  In	  recent	  years,	  the	  discovery	  of	  new	  signaling	  
molecules	   in	   bacteria	   and	   archaea	   and	   the	   pathways	   they	   regulate	   has	  
brought	   insights	   into	   signaling	   mechanisms	   not	   only	   in	   bacterial	   and	  
archaeal	   cells	   but	   also	   in	   eukaryotic	   host	   cells.	   Here,	   we	   provide	   an	  
overview	   of	   the	   synthesis	   and	   regulation	   of	   c-­‐di-­‐AMP,	   one	   of	   the	   latest	  
cyclic	  nucleotide	  second	  messengers	  to	  be	  discovered	  in	  bacteria.	  We	  will	  
also	   discuss	   currently	   known	   receptor	   proteins	   and	   pathways	   that	   are	  
directly	  or	   indirectly	   controlled	  by	   c-­‐di-­‐AMP,	   the	  domain	   structure	  of	   the	  
enzymes	  involved	  in	  its	  production	  and	  degradation	  and	  the	  recognition	  of	  
c-­‐di-­‐AMP	  by	  the	  eukaryotic	  host.	  	  
	  Nucleotides	  are	  indispensible	  components	  of	  all	  living	  cells	  as	  they	  make	  up	  DNA	  and	  RNA,	  and	  serve	  as	  important	  energy	  sources.	  In	  addition	  to	  these	  functions,	  nucleotides	  also	  play	  key	  roles	  in	  signaling	  in	  eukaryotic,	  bacterial	  and	  archaeal	  cells.	  In	  bacteria,	  signaling	  nucleotides	  such	  as	  cyclic	  adenosine	  monophosphate	  (cAMP)	  and	  guanosine	  tetra-­‐or	  pentaphosphate	  (p)ppGpp	  have	  been	  classically	  linked	   to	   carbon	   metabolism	   and	   the	   stringent	   response,	   which	   is	   caused	   by	  nutrient	   limitation1,	  2.	   However,	   it	   has	   become	   clear	   that	   signaling	   nucleotides	  can	  also	  contribute	  to	  the	  regulation	  of	  multiple	  different	  pathways;	  for	  example	  in	   addition	   to	   its	   involvement	   in	   central	   carbon	   metabolism	   cAMP	   is	   also	  involved	   in	   the	   regulation	   of	   both	   biofilm	   formation	   and	   virulence	   gene	  expression	  in	  many	  pathogenic	  bacteria1.	  One	  of	  the	  latest	  signaling	  nucleotides	  to	   be	   identified	   is	   cyclic	   diadenosine	   monophosphate	   (c-­‐di-­‐AMP),	   which	   after	  cyclic	   diguanosine	   monophosphate	   (c-­‐di-­‐GMP)3	   (Box	   1)	   is	   the	   second	   cyclic	  dinucleotide	   that	   has	   been	   shown	   to	   be	   produced	   by	   bacteria,	   but	   as	   will	   be	  described	  here,	  regulates	  very	  different	  processes.	  	  
	   c-­‐di-­‐AMP	  is	  produced	  from	  two	  molecules	  of	  ATP	  by	  diadenylate	  cyclase	  (DAC)	   enzymes	   and	   degraded	   to	   pApA	   by	   phosphodiesterase	   (PDE)	   enzymes	  (FIG.	  1).	  It	  was	  initially	  discovered	  during	  a	  structural	  study	  on	  the	  Thermotoga	  
maritima	   protein	   DisA4,	   a	   homologue	   of	   the	   Bacillus	   subtilis	   DNA	   integrity	  scanning	  protein	  DisA	  (formally	  YacK).	  This	  protein	   is	  a	  bacterial	  DNA	  damage	  checkpoint	  protein	  that	  can	  delay	  sporulation	  in	  the	  event	  of	  DNA	  damage5.	  The	  first	  report	  of	  c-­‐di-­‐AMP	  production	  by	  bacterial	  cells	  came	  in	  2010,	  when	  it	  was	  identified	  as	  a	  molecule	  secreted	  into	  the	  cytosol	  of	  host	  cells	  by	  the	  intracellular	  bacterial	   pathogen	  Listeria	  monocytogenes6.	   Since	   then,	   it	   has	   been	  detected	   in	  cellular	   extracts	   from	   Streptococcus	   pyogenes7,	   B.	   subtilis8,	   Chlamydia	  
trachomatis9	  and	  Staphylococcus	  aureus10	  and	  a	  DisA-­‐type	  c-­‐di-­‐AMP	  synthesizing	  enzyme	   from	   Mycobacterium	   tuberculosis	   has	   been	   characterized	  biochemically11.	  As	  previously	  suggested12	  and	   further	  analyzed	  here,	  c-­‐di-­‐AMP	  is	  likely	  to	  be	  widely	  distributed	  among	  bacteria	  and	  is	  also	  found	  in	  a	  subset	  of	  archaea.	   Based	   on	   the	   domain	   architecture,	   here	   we	   propose	   a	   unifying	  nomenclature	  for	  DAC	  enzymes.	  The	  regulation	  of	  cellular	  pathways	  by	  c-­‐di-­‐AMP	  presumably	  follows	  the	  same	   general	   principles	   as	   for	   other	   signaling	   nucleotides,	   although	   most	  mechanistic	   details	   of	   c-­‐di-­‐AMP	   signaling	   are	   still	   awaiting	   molecular	  characterization.	  Environmental	  changes	  are	  sensed	  either	  directly	  or	  indirectly	  by	  the	  nucleotide	  synthesizing	  or	  degrading	  enzymes,	  leading	  to	  a	  change	  in	  the	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cellular	  nucleotide	  concentration.	  At	  a	  high	  concentration,	  c-­‐di-­‐AMP	  is	  expected	  to	  bind	  to	  a	  specific	  set	  of	  receptor	  or	  target	  proteins	  and	  allosterically	  alter	  their	  function	   or	   the	   function	   of	   downstream	   effector	   proteins.	   In	   this	  manner	   c-­‐di-­‐AMP	  signaling	  could	  control	  specific	  cellular	  pathways	  (FIG.	  1).	  Although	  many	  details	   of	   the	   c-­‐di-­‐AMP	   signaling	   network	   remain	   to	   be	   discovered,	   this	  nucleotide	   has	   now	   been	   linked	   to	   the	   regulation	   of	   fatty	   acid	   synthesis	   in	  
Mycobacterium	   smegmatis13,	   to	   the	   growth	   of	   S.	   aureus	   in	   low	   potassium	  conditions14,	   to	   the	   sensing	  of	  DNA	   integrity	   in	  B.	  subtilis5,	  8,	  15,	   and	   to	   cell	  wall	  homeostasis	   in	  multiple	   species10,	  16-­‐19.	   In	   this	   Progress	   article,	  we	  will	   discuss	  the	  synthesis	  and	  regulation	  of	   c-­‐di-­‐AMP,	   the	  domain	  structure	  of	   the	  enzymes	  involved	   in	   its	   production	   and	   degradation	   and	   our	   current	   understanding	   of	  how	   this	   second	   messenger	   is	   involved	   in	   the	   control	   of	   diverse	   cellular	  pathways.	  
	  
Synthesis	  of	  c-­‐di-­‐AMP	  	  c-­‐di-­‐AMP	   is	   synthesized	   from	   two	   ATP	   molecules	   by	   proteins	   containing	   a	  DisA_N	  domain	  (Pfam02457)	  (FIG.	  1).	  This	  domain	  was	  first	  identified	  as	  a	  c-­‐di-­‐AMP	  cyclase	  domain	  in	  the	  T.	  maritima	  DisA	  protein4.	  Based	  on	  its	  function	  as	  a	  diadenylate	   cyclase,	   DisA_N	   will	   be	   referred	   to	   hereafter	   as	   a	   DAC	   domain	  (diadenylate	  cyclase).	  In	  DisA	  proteins	  the	  N-­‐terminal	  DAC	  domain	  is	  connected	  through	   a	   specific	   linker	   domain	   (DisA_N	   linker;	   Pfam10635)	   to	   a	   C-­‐terminal	  helix-­‐hairpin-­‐helix	   (HhH;	   Pfam12826)	   DNA-­‐binding	   domain.	   Eight	   DisA	  monomers	   form	   the	   functional	   octameric	   protein	   complex4.	   During	  crystallization	   studies	   on	   the	   T.	   maritima	   DisA	   an	   extra	   electron	   density	   was	  noted	  within	   the	   DAC	   domain	   and	  was	   identified	   as	   c-­‐di-­‐AMP4.	   It	   was	   further	  shown	  that	  in	  the	  presence	  of	  divalent	  cations	  DisA	  proteins	  synthesize	  c-­‐di-­‐AMP	  through	   the	   condensation	   of	   two	  molecules	   of	   ATP,	   each	   bound	   to	   a	   different	  subunit	  of	   the	  octamer4,	  11.	  The	   ligand-­‐bound	  crystal	  structure	  of	  DisA	  revealed	  the	  presence	  of	  DGA	  and	  RHR	  motifs	  within	  the	  DAC	  domain4.	  These	  motifs	  are	  conserved	   within	   all	   bacterial	   DAC	   domain-­‐containing	   proteins	   and	   a	   crucial	  function	   for	   these	   motifs	   in	   the	   cyclase	   reaction	   has	   been	   confirmed	  experimentally4,	  11.	  The	  DAC	  domain	  bears	  no	  amino	  acid	  or	  structural	  similarity	  to	  the	  c-­‐di-­‐GMP	   cyclase	   GGDEF	  domain	   (Pfam00990).	   The	   observation	   that	   evolutionarily	  unrelated	   proteins	   have	   evolved	   for	   the	   synthesis	   of	   cyclic	   dinucleotides	   is	  further	   underscored	   by	   the	   recent	   identification	   of	   the	   dinucleotide	   cyclase	  DncV,	  which	  produces	  c-­‐AMP-­‐GMP	  (cGAMP(3’-­‐5’))	  in	  Vibrio	  cholerae20.	  DncV	  has	  been	   placed	   within	   a	   separate	   protein	   family,	   the	   nucleotidyl	   transferase	  superfamily	   (NTS),	   based	   on	   key	   amino	   acids	   it	   shares	   with	   2’-­‐5’-­‐oligoadenyl	  synthases	  (OAS1)	  and	  poly(A)	  polymerases20.	  DncV	  can	  also	  synthesize	  c-­‐di-­‐AMP	  
in	   vitro	   and	   when	   overexpressed	   in	   Escherichia	   coli20.	   However,	   only	   the	  cGAMP(3’-­‐5’)	  hybrid	  nucleotide	  was	  detected	  in	  V.	  cholerae	  extracts20,	  suggesting	  that	  the	  c-­‐di-­‐AMP	  activity	  of	  DncV	  may	  not	  be	  physiological	  relevant.	  Currently,	  the	   DAC	   domain	   is	   the	   only	   bona	   fide	   c-­‐di-­‐AMP	   cyclase	   domain	   known.	   The	  finding	  that	  the	  different	  cyclic	  dinucleotides	  are	  produced	  by	  non-­‐homologous	  enzymes	   might	   be	   somewhat	   surprising	   since	   it	   seems	   easier	   to	   reprogram	   a	  DGC	  to	  synthesize	  c-­‐di-­‐AMP	  instead	  of	  evolving	  an	  new	  cyclase.	  However,	  it	  has	  already	  been	  noted	  previously	  that	  the	  six	  different	  classes	  of	  prokaryotic	  cAMP	  cyclases	  do	  not	  have	  a	  common	  origin21.	  This	  highlights	  that	  enzymes	  involved	  in	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the	   synthesis	   of	   the	   same	   signaling	   nucleotide	   may	   have	   evolved	   multiple	  times21.	  	  To	  date,	  1,956	  DAC	  domain-­‐containing	  sequences	  within	  1,438	  organisms	  can	  be	   found	   in	   the	  Pfam	  database	  (Table	  S1)22.	  The	  majority	  of	   these	  proteins	  are	   found	   in	   bacterial	   species	   but	   a	   small	   number	   are	   also	   present	   in	   archaea	  within	  the	  Euryarchaeota	  group	  (Box	  2)12.	  In	  bacteria,	  DAC	  domain	  proteins	  are	  most	  frequently	  found	  in	  the	  Gram-­‐positive	  Firmicutes	  and	  within	  the	  phylum	  of	  Actinobacteria.	   In	   addition,	   the	   DAC	   domain	   is	   also	   found	   in	   Gram-­‐negative	  bacteria,	  including	  the	  genera	  Bacteroidetes,	  Deltaproteobacteria,	  Cyanobacteria	  Chlamydiae	  and	  Fusobacteria	  (Table	  S1).	   Interestingly,	  most	  organisms	  contain	  only	   a	   single	   c-­‐di-­‐AMP	   cyclase,	   and	   organisms	   containing	   two	   or	   three	   DAC	  domains	  such	  as	  some	  Clostridium	   and	  Bacillus	   species	  are	  rather	  an	  exception	  (Table	   S1).	   This	   is	   in	   contrast	   to	   c-­‐di-­‐GMP	   production,	   where	  most	   organisms	  contain	  multiple	   c-­‐di-­‐GMP	   cyclases.	  The	  distribution	  of	   c-­‐di-­‐GMP	  and	   c-­‐di-­‐AMP	  synthesizing	  and	  degrading	  enzymes	  among	  bacteria	   is	  also	  different.	  The	  c-­‐di-­‐GMP	  turnover	  enzymes	  are	  especially	  abundant	  among	  Proteobacteria,	  and	  there	  not	  only	  found	  in	  deltaproteobacteria,	  which	  potentially	  also	  encode	  a	  c-­‐di-­‐AMP	  synthase,	   but	   widespread	   among	   alpha-­‐,	   beta-­‐	   and	   gamma-­‐proteobacteria,	  organisms	   that	   lack	   a	   c-­‐di-­‐AMP	   signaling	   system23-­‐25.	   On	   the	   other	   hand,	   c-­‐di-­‐GMP	   turnover	   enzymes	   have	   been	   reported	   to	   be	   absent	   in	   Bacteroidetes,	  Chlamydiales	  and	  Fusobacteria25,	  which	  potentially	  encode	  a	  c-­‐di-­‐AMP	  synthesis	  enzyme.	  However	   the	  signaling	  systems	  are	  not	  mutually	  exclusive	  and	  several	  bacteria	   appear	   to	   contain	   both	   systems.	   Among	   the	   Firmicutes	   and	  Actinobacteria	   for	   instance,	   bacteria	   belonging	   to	  Bacillus,	  Clostridium,	  Listeria,	  
Mycobacterium	  and	  Streptomyces	  spp.	  appear	  to	  contain	  both	  signaling	  systems,	  while	   other	   species	   such	   as	  Staphylococcus,	  Streptococcus	  and	  Corynebacterium	  no	  longer	  encode	  a	  functional	  c-­‐di-­‐GMP	  system.	  However	  as	  discussed	  later,	  the	  presence	   of	   degenerated	   GGDEF	   domains	   in	   Staphylococcus	   and	   Streptococcus	  spp.	   could	  be	  a	   remnant	  of	   the	  c-­‐di-­‐GMP	  system,	  which	   interestingly	  have	  now	  been	  rewired	  to	  function	  in	  the	  c-­‐di-­‐AMP	  signaling	  system.	  	  
Architecture	  of	  bacterial	  DAC	  domain	  proteins	  	  
DacA.	   Although	   the	   exact	   function	   of	   most	   DAC	   domain-­‐containing	   proteins	  remains	   unknown,	   analysis	   of	   associated	   domains	   or	   the	   operon	   structure	   in	  which	  DACs	  are	  encoded	  can	  provide	  insights	  into	  the	  role	  of	  these	  proteins.	  The	  most	  abundant	  domain	  architecture	   for	  bacterial	  DAC	  proteins	   is	  one	   in	  which	  the	  DAC	  domain	   follows	  an	  N-­‐terminal	   transmembrane	  domain	   (FIG.	  2).	  Based	  on	   the	   nomenclature	   already	   used	   in	   several	   bacteria,	   a	   protein	   with	   this	  architecture	   is	   suggested	   to	   be	   referred	   to	   as	   DacA	   for	   diadenylate	   cyclase	  protein	   A	   (FIG.	   2	   and	   Table	   S1).	   It	   is	   plausible	   that	   the	  membrane	   domain	   of	  DacA	   acts	   as	   a	   sensory	   domain,	   directly	   sensing	   specific	   changes	   within	   the	  membrane	  or	  cell	  wall	  and	  adjusting	  c-­‐di-­‐AMP	  production	  accordingly.	  It	  has	  also	  been	  noted	  that	  the	  dacA	  gene	  is	  often	  found	  in	  an	  operon	  with	  a	  gene	  encoding	  a	  protein	  with	  one	  or	  multiple	  YbbR	  domains	  (Pfam07949)12	  (Table	  S1).	  In	  a	  few	  instances	  the	  YbbR	  domains	  are	  directly	  fused	  to	  DacA,	  and	  to	  distinguish	  these	  proteins	  from	  DacA	  proteins	  the	  fusions	  will	  be	  referred	  to	  as	  DacC	  proteins	  (FIG.	  2).	   YbbR	   domains	   usually	   follow	   an	   N-­‐terminal	   transmembrane	   helix	   and	  membrane	   topology	   predictions	   place	   them	   on	   the	   outside	   of	   the	   cell.	   It	   has	  recently	  been	  shown	  that	  YbbR	  (also	  named	  CdaR	  for	  cyclic	  di-­‐AMP	  synthase	  A	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regulator15)	  from	  B.	  subtilis	  physically	  interacts	  with	  DacA	  and	  stimulates	  cyclase	  activity15.	   The	   structures	   of	   two	   of	   the	   four	   YbbR	   domain-­‐containing	   proteins	  from	   Desulfitobacterium	   hafniense	   Y51	   have	   been	   solved	   by	   NMR	   and	   X-­‐ray	  crystallography26.	   It	  was	  noted	  that	   the	  YbbR	  domains	  assume	  a	  similar	   fold	  to	  the	  C-­‐terminal	  domain	  of	  the	  ribosomal	  proteins	  TL5	  from	  Thermus	  thermophilus	  and	   L25	   from	   Deinococcus	   radiodurans27,	   28.	   It	   has	   been	   suggested	   that	   this	  domain	  serves	  to	  stabilize	  the	  interaction	  between	  the	  5S	  rRNA,	  to	  which	  these	  proteins	  bind,	   and	   the	  23S	   rRNA	  via	  an	   interaction	  with	   the	  23S	   rRNA-­‐binding	  ribosomal	  protein	  L1626,	  highlighting	  that	  a	  protein	  with	  a	  similar	   fold	  to	  YbbR	  can	   bind	   both	   RNA	   and	   proteins.	   Therefore,	   it	   seems	   plausible	   that	   the	  extracellular	  YbbR	  domains	  of	  YbbR	  serve	  as	  sensory	  domains	  of	  a	  yet	  unknown	  signal	  and	  ligand	  in	  order	  to	  regulate	  the	  activity	  of	  DacA.	  	  The	   dacA	   operon	   is	   frequently	   extended	   to	   include	   the	   glucosamine-­‐1-­‐phosphate	  mutase	  gene	   (glmM),	  which	  encodes	  a	  protein	   involved	   in	   an	   initial	  step	   of	   peptidoglycan	   synthesis.	   In	  B.	  subtilis	   this	   three	   gene	  dacA,	  ybbR,	  glmM	  operon	   is	   constitutively	   expressed	   from	   a	   housekeeping	   sigma	   factor	   SigA	  dependent	  promoter15,	  16.	  Along	  with	  the	  observed	  changes	  in	  cell	  wall	  structures	  in	  bacteria	  with	  altered	  c-­‐di-­‐AMP	  levels	  that	  are	  discussed	  later,	  this	  suggests	  a	  link	  between	  c-­‐di-­‐AMP	  and	  cell	  wall	  synthesis	  and	  homeostasis.	  	  
DisA.	  The	   second	  most	   common	   group	   of	   DAC	   domain-­‐containing	   proteins	   are	  DisA-­‐like	   proteins	   in	   which	   the	   DAC	   domain	   is	   connected	   through	   a	   specific	  linker	  region	  to	  a	  DNA	  binding	  domain	  (FIG.	  2).	  Such	  DisA	  proteins	  are	  found	  in	  some	   Gram-­‐negative	   bacteria	   but	   are	   mostly	   present	   in	   the	   Gram-­‐positive	  bacterial	   spore-­‐forming	  Bacillus	   and	  Clostridium	  spp.	   and	   in	   the	  Actinobacteria	  (Table	  S1).	  DisA	  has	  been	  assigned	  a	  function	  as	  a	  direct	  sensor	  of	  DNA	  integrity	  prior	  to	  spore	  formation	  and	  protein	  levels	  were	  shown	  to	  increase	  at	  a	  high	  cell	  density	   and	   at	   the	   onset	   of	   sporulation14,15.	   It	   is	   interesting	   to	   note	   that	   in	   B.	  
subtilis,	  the	  disA	  gene	  is	  encoded	  in	  a	  large	  operon	  together	  with	  radA,	  encoding	  for	  a	  DNA	  repair	  protein	  and	  clpC	  and	  its	  accessory	  genes	  mcsA	  and	  mcsB,	  which	  are	  involved	  in	  degrading	  damaged	  proteins	  particular	  during	  heat	  stress29.	  This	  large	  operon	   is	  proceeded	  by	  SigA	   (housekeeping)	  and	  SigB	   (stationary	  phase)	  dependent	   promoters30.	   Expression	   of	  disA	   is	   further	   controlled	   by	   an	   internal	  SigM	   dependent	   promoter	   that	   is	   activated	   by	   cell	   envelope	   stresses	   such	   as	  those	   elicited	   by	   antibiotics16,	   30,	   31.	   The	   observation	   that	   disA	   expression	   is	  controlled	  by	  multiple	  promoters	  could	  suggest	  that	  DisA	  and	  hence	  c-­‐di-­‐AMP	  is	  important	  to	  ensure	  DNA	  integrity	  during	  multiple	  stresses	  and	  perhaps	  not	  only	  when	   bacteria	   enter	   sporulation.	   The	   function	   of	   the	   DisA	   homologues	   in	  Actinobacteria	   has	   not	   yet	   been	   studied.	  However,	   since	  Streptomyces	  spp.	   are	  also	   spore-­‐forming	   bacteria	   and	   the	   slow	   growing	  Mycobacterium	  spp.	   enter	   a	  dormant	  state,	   it	   seems	   likely	   that,	  at	   least	   in	   these	  species,	  DisA	  and	  c-­‐di-­‐AMP	  ensure	  DNA	  integrity	  during	  these	  developmental	  processes.	  	  
DacB.	  The	   third	   most	   prevalent	   DAC	   domain-­‐containing	   proteins	   are	   those	   in	  which	   a	   YojJ	   domain	   (Pfam10372)	   precedes	   the	   DAC	   domain	   (FIG.	   2);	   these	  proteins	  are,	  with	  one	  exception,	  specific	  to	  the	  Bacillales	  (Table	  S1).	  To	  provide	  a	   consistent	   nomenclature,	   proteins	   with	   this	   domain	   architecture	   will	   be	  referred	   to	   as	   DacB	   for	   diadenylate	   cyclase	   protein	   B.	   The	   structure	   of	   the	  
Bacillus	   cereus	  DacB	  protein	   (PDB	   number	   2fb5)	   revealed	   that	   the	   N-­‐terminal	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YojJ	  domain	  forms	  an	  orthogonal	  bundle	  of	  long	  alpha	  helices	  that	  are	  followed	  by	  the	  DAC	  domain,	  which	  as	  expected	  has	  the	  same	  fold	  as	  the	  DAC	  domain	  of	  DisA4.	   A	   function	   as	   a	   c-­‐di-­‐AMP	   cyclase	   has	   been	   confirmed	   for	   the	  B.	   subtilis	  DacB	  protein15,	  16.	  DacB	  does	  not	  appear	  to	  be	  expressed	  in	  vegetative	  B.	  subtilis	  cells15	   though	   its	   expression	   has	   been	   shown	   to	   increase	   during	   sporulation32.	  Based	  on	   these	   transcription	  data	   it	  has	  been	  suggested	   that	  dacB	  is	  under	   the	  control	  of	   the	   late	   forespore-­‐specific	  sigma	   factor	  SigG15,	  32	  and	  hence	  c-­‐di-­‐AMP	  produced	  by	  DacB	  is	  likely	  to	  control	  sporulation	  specific	  processes.	  	  	  
Other	  bacterial	  DAC	  domain-­‐containing	  proteins.	  DacA,	  DisA	  and	  DacB	  represent	  more	   than	  98.7%	  of	   all	   bacterial	  DAC	  domain-­‐containing	  proteins	   identified	   to	  date	   (FIG.	   2).	   For	   the	   remaining	   proteins,	   the	   DAC	   domain	   is	   preceded	   in	   six	  cases	   by	   a	   phosphoenolpyruvate-­‐dependent	   sugar	   phosphotransferase	   system	  EIIA	  (Pfam00359),	  indicating	  a	  possible	  link	  between	  sugar	  import	  and	  c-­‐di-­‐AMP	  synthesis	  in	  these	  organisms.	  In	  two	  cases	  the	  DAC	  domain	  is	  linked	  to	  differing	  tetricopeptide	  repeat	  (TPR:	  Pfam00515,	  Pfam13414,	  Pfam13424)	  domains	  that	  are	  thought	  to	  mediate	  protein-­‐protein	  interactions	  and	  in	  one	  case	  it	  is	  fused	  to	  a	  domain	  of	  unknown	  function	  (DUF4062:	  Pfam13271)	  (Table	  S1	  and	  FIG.	  2).	  To	  provide	  a	  consistent	  nomenclature,	  we	  propose	  to	  rename	  these	  proteins	  DacD,	  DacE	  and	  DacF,	  respectively	  (Table	  S1	  and	  FIG.	  2).	  	  	  
Degradation	  of	  c-­‐di-­‐AMP	  Following	   the	   discovery	   of	   c-­‐di-­‐AMP	   synthesizing	   proteins,	   the	  B.	   subtilis	   PDE	  enzyme	  YybT,	  which	  can	  hydrolyze	  c-­‐di-­‐AMP,	  was	  discovered33.	  This	  protein	  will	  be	  referred	  to	  as	  GdpP	  for	  GGDEF	  domain	  protein	  containing	  phosphodiesterase,	  for	   consistency	   in	   nomenclature	  with	   homologues	   in	   other	   bacteria.	   The	   gdpP	  gene	   is	   in	  an	  operon	  with	  rplI,	   the	  gene	  encoding	   for	   the	  ribosomal	  protein	  L9,	  and	  is	  also	  frequently	  located	  close	  to,	  if	  not	  in	  an	  operon	  with,	  the	  gene	  encoding	  for	  DnaC,	  a	  protein	   important	   for	  DNA	  replication.	  Expression	  of	   the	  c-­‐di-­‐AMP-­‐	  specific	   PDE	   together	   with	   a	   ribosomal	   and	   a	   DNA	   replication	   protein	   might	  suggest	  that	  it	  is	  important	  to	  keep	  c-­‐di-­‐AMP	  levels	  low	  during	  active	  growth	  and	  replication.	  Recently	  it	  has	  been	  reported	  that	  gdpP	  expression	  itself	  is	  regulated	  in	  B.	  subtilis	  by	  an	  antisense	  transcript	  under	  the	  control	  of	  SigD34	   .	  However,	  if	  and	   how	   this	   antisense	   regulation	   translates	   into	   changes	   in	   cellular	   c-­‐di-­‐AMP	  levels	   awaits	   further	   investigation.	   The	   GdpP	   protein	   contains	   two	  transmembrane	   helices,	   a	   degenerate	   PAS	   sensory	   domain	   (Pfam00989),	   a	  highly	  divergent	  GGDEF	  domain	  (Pfam00990),	  a	  DHH	  domain	  (Pfam01368)	  and	  a	   DHH-­‐associated	   DHHA1	   domain	   (Pfam02272)	   (FIG.	   2).	   The	   PDE	   activity	   is	  contained	  within	  the	  C-­‐terminal	  DHH/DHHA1	  region,	  which	  efficiently	  degrades	  c-­‐di-­‐AMP	  to	  5’-­‐pApA	  (FIG.	  1)	  with	  a	  Michaelis-­‐Menten	  constant	  (Km)	  of	  1.3	  +/-­‐	  0.3	   μM33.	   GdpP	   requires	   Mn2+	   for	   activity	   and	   mutations	   of	   predicted	   and	  conserved	  metal	  binding	  residues	  abrogate	  the	  PDE	  activity	  of	  the	  B.	  subtilis	  and	  
S.	  aureus	  GdpP	  enzymes10,	  33.	  Using	  an	  in	  vitro	  assay,	  it	  has	  been	  shown	  that	  heme	  binding	  to	  the	  PAS	  domain	  suppresses	  the	  PDE	  activity	  of	  GdpP	  while	  nitric	  oxide	  (NO)	   coordination	   by	   heme	   stimulates	   the	   PDE	   activity35.	   This	   suggests	   that	  GdpP	  is	  a	  heme	  and/or	  NO	  sensor	  and	  coordinates	  the	  degradation	  of	  c-­‐di-­‐AMP	  accordingly.	   GdpP	   also	   contains	   a	   highly	   modified	   GGDEF	   domain.	   GGDEF	  domains	  are	  typically	  associated	  with	  proteins	  involved	  in	  the	  synthesis	  of	  c-­‐di-­‐GMP,	  in	  which	  two	  GGDEF	  domains,	  each	  bound	  to	  one	  molecule	  of	  GTP,	  produce	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c-­‐di-­‐GMP36.	  However	   in	   some	   instances,	  when	  a	  GGDEF	  and	  a	  PDE	  domain	  are	  present	   within	   a	   single	   protein,	   such	   as	   in	   PdeA	   from	   Caulobacter	   crescentus,	  binding	  of	  GTP	  does	  not	  result	  in	  the	  synthesis	  of	  c-­‐di-­‐GMP	  but	  instead	  regulates	  the	   activity	   of	   the	  PDE	  domain37.	   The	  GGDEF	  motif	   in	  GdpP	   is	   highly	  modified	  and	   produces	   neither	   c-­‐di-­‐GMP	   nor	   c-­‐di-­‐AMP33.	   Instead,	   it	   binds	   and	   slowly	  hydrolyzes	   ATP	   to	   ADP33,	   but	   the	   physiological	   relevance	   of	   this	   enzymatic	  activity	  remains	  to	  be	  determined.	  Binding	  of	  a	  non-­‐hydrolysable	  ATP	  analogue	  did	  not	  affect	  the	  PDE	  activity33,	  however	  mutations	  of	  several	  conserved	  amino	  acids	  within	  the	  GGDEF	  domain	  in	  S.	  aureus	  GdpP	  significantly	  reduced	  c-­‐di-­‐AMP	  hydrolysis10,	   suggesting	   a	   regulatory	   function	   for	   this	   domain.	   It	   is	   also	  interesting	   to	   note	   that	   the	   stringent	   response	   signaling	   molecule	   ppGpp	   is	   a	  strong	   competitive	   inhibitor	   of	   GdpP	   activity	   in	  vitro33.	   This	   not	   only	   links	   the	  networks	   of	   two	   different	   signaling	   nucleotides	   but	   also	   suggests	   that	   under	  stringent	   response	   stress	   conditions	   cellular	   c-­‐di-­‐AMP	   levels	   will	   increase	  through	  a	  decrease	  in	  PDE	  activity.	  	  GdpP-­‐type	  proteins	   containing	  a	  PAS,	  GGDEF	  and	   the	  DHH/DHHA1	  PDE	  domains	   are	   only	   found	   in	   Firmicutes	   and	   in	   Tenericutes	   (Table	   S1)	   and	  therefore	   yet	   to	   be	   identified	   proteins	   with	   different	   domain	   architectures,	  potentially	  containing	  a	  DHH/DHHA1	  domain	  associated	  with	  a	  different	  sensory	  domain,	  must	  be	  responsible	  for	  c-­‐di-­‐AMP	  degradation	  in	  the	  other	  bacteria	  (FIG.	  2).	  Potential	  c-­‐di-­‐AMP	  hydrolyzing	  enzymes	  of	  archaea	  are	  discussed	  in	  Box	  2.	  
	  	  
c-­‐di-­‐AMP	  -­‐	  an	  essential	  second	  messenger	  The	  first	  report	  of	  c-­‐di-­‐AMP	  production	  by	  bacterial	  cells	  came	  in	  2010,	  when	  it	  was	   identified	   as	   a	   molecule	   secreted	   into	   the	   cytosol	   of	   host	   cells	   by	   the	  intracellular	  pathogen	  L.	  monocytogenes6.	  As	  much	  as	  18	  nM	  of	   c-­‐di-­‐AMP	  were	  detected	   in	   the	   supernatant	   of	   wildtype	   L.	   monocytogenes	   cultures,	   which	  increased	   to	   53	   nM	   upon	   over-­‐expression	   of	   multidrug	   efflux	   pumps6.	  Subsequently,	   intracellular	  c-­‐di-­‐AMP	  concentrations	  of	  1.7	  μM	  and	  2.1	  μM	  have	  been	  measured	   in	   cytoplasmic	  extracts	  of	  B.	  subtilis	  and	  S.	  aureus	  cells	   and	   the	  concentrations	   increased	   4-­‐	   or	   15-­‐fold	   above	  wildtype	   levels	   in	   the	   respective	  
gdpP	  mutant	  strains8,	  10.	  These	  nucleotide	  concentrations	  are	   in	  a	  similar	  range	  as	  those	  reported	  for	  c-­‐di-­‐GMP38,	  39.	  Following	  the	  identification	  of	  c-­‐di-­‐AMP	  in	  L.	  
monocytogenes	   and	   S.	   pyogenes,	   attempts	   to	   delete	   the	   dacA	   gene	   proved	  unsuccessful,	  hinting	   that	   the	  cyclase,	  and	  hence	  c-­‐di-­‐AMP,	   is	  essential	   in	   these	  bacteria6,	   7,	   40.	   These	   results	   are	   also	   in	   line	   with	   genome	   wide	   screens	   for	  essential	   genes	   in	  Mycoplasma	  pulmonis,	  Mycoplasma	  genitalium,	   Streptococcus	  
pneumoniae	  and	  S.	  aureus41-­‐44,	  all	  of	  which	  reported	  an	  inability	  to	  disrupt	  dacA.	  Furthermore,	  a	  B.	  subtilis	  mutant	  with	  deletions	  in	  all	  three	  cyclases	  genes	  (disA,	  
dacABS	  and	  dacBBS)	  could	  not	  be	  obtained,	  however	  ectopic	  expression	  of	  any	  of	  the	   three	   cyclases	   was	   enough	   to	   fully	   rescue	   cells	   suggesting	   that	   all	   three	  proteins	   are	   active	   cyclases	   when	   expressed16,15.	   As	   c-­‐di-­‐AMP	   is	   produced	   by	  many	  important	  human	  pathogens	  these	  observations	  make	  the	  identification	  of	  the	  cellular	  pathways	   that	  are	  regulated	  by	  c-­‐di-­‐AMP	  of	  great	   interest	  with	   the	  view	  of	  possibly	  exploiting	  them	  to	  develop	  new	  therapeutic	  interventions.	  	  
c-­‐di-­‐AMP	  receptor	  proteins	  
TetR-­‐family	  transcription	  factor	  DarR.	  Signaling	  nucleotides	   function	  by	  binding	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to	  specific	  receptor	  proteins	  to	  allosterically	  alter	  their	  activity	  and	  thus	  regulate	  specific	   cellular	   pathways.	   The	   first	   c-­‐di-­‐AMP	   receptor	   protein	   reported	   in	   the	  literature	  was	  the	  M.	  smegmatis	  protein	  Ms5346,	  a	  TetR-­‐family	  regulator	  protein	  that	  was	  renamed	  DarR	  for	  c-­‐di-­‐AMP	  receptor	  regulator.	  DarR	  was	  identified	  by	  screening	  a	  library	  of	  about	  500	  predicted	  M.	  smegmatis	  transcription	  factors	  for	  their	  ability	  to	  bind	  radiolabeled	  c-­‐di-­‐AMP13.	  Using	  surface	  plasmon	  resonance,	  a	  specific	  interaction	  with	  a	  Kd	  of	  2.5	  µM	  was	  revealed	  between	  purified	  DarR	  and	  c-­‐di-­‐AMP.	   DarR	   has	   a	   two-­‐domain	   architecture	   with	   an	   N-­‐terminal	   TetR-­‐like	  helix-­‐turn-­‐helix	   domain	   (Pfam00440),	   a	   typical	   DNA-­‐binding	   domain,	   and	   a	   C-­‐terminal	   QacR-­‐like	   (Pfam08360)	   domain13	   (FIG.	   3).	   Proteins	   containing	   QacR-­‐like	  domains	  are	  not	  universally	  present	  in	  organisms	  that	  are	  likely	  to	  produce	  c-­‐di-­‐AMP,	  however	  this	  domain	  is	  for	  instance	  present	  in	  QacR,	  a	  protein	  found	  in	   some	   S.	   aureus	   strains,	   FadR	   from	   B.	   subtilis	   and	   AcrR	   from	  Pelotomaculum 
thermopropionicum13.	   In	  M.	   smegmatis,	  DarR	  was	   shown	   to	   bind	   to	   and	   repress	  transcription	  of	  its	  own	  promoter,	  to	  control	  the	  divergently	  transcribed	  operon	  encoding	   a	   medium-­‐chain	   fatty	   acyl-­‐CoA	   ligase	   and	   a	   major	   facilitator	   family	  transporter,	   as	  well	   as	   to	   repress	   transcription	  of	   a	  gene	  encoding	   for	   the	  cold	  shock	   protein	   CspA	   (FIG.	   4).	   Deletion	   of	   darR	   in	   M.	   smegmatis	   leads	   to	   an	  increase	   in	  cell	  size,	  whilst	  overexpression	   is	   toxic	   to	   the	  bacteria	  and	  causes	  a	  marked	   decrease	   in	   fatty	   acid	   synthesis13.	   The	   DNA-­‐binding	   ability	   of	   DarR	   is	  enhanced	   in	  vitro	  upon	   interaction	  with	   c-­‐di-­‐AMP13,	   suggesting	   that	   changes	   in	  cellular	   c-­‐di-­‐AMP	   levels	   might	   affect	   fatty	   acid	   synthesis	   in	   M.	   smegmatis.	  However,	   additional	   experimental	   evidence	   is	   needed	   to	   unambiguously	   show	  that	   c-­‐di-­‐AMP	   affects	   membrane	   lipid	   homeostasis	   in	   M.	   smegmatis	   or	   other	  bacteria	  (FIG.	  4).	  	  	  
RCK_C	   domain	   proteins	   KtrA	   and	   CpaA.	   Using	   c-­‐di-­‐AMP	   coupled	   beads	   and	   S.	  
aureus	   cytoplasmic	   protein	   extracts	   in	   affinity	   pull	   down	   assays,	   the	   S.	   aureus	  protein	  KtrA,	   a	   cytoplasmic	   gating	   component	   of	  Ktr-­‐type	  potassium	   transport	  systems,	  was	   identified	   as	   a	   second	   c-­‐di-­‐AMP	   receptor	   protein14.	   Purified	  KtrA	  protein	  bound	  c-­‐di-­‐AMP	  with	  a	  higher	  affinity	  compared	  to	  DarR	  and	  a	  Kd	  below	  100	   nM	   was	   measured14.	   KtrA	   forms,	   together	   with	   a	   KtrB-­‐type	   membrane	  component,	  a	  potassium	  transporter	  that	  is	  widely	  distributed	  among	  bacteria45,	  46	  (FIG.	  3).	  KtrA	  is	  a	  member	  of	  the	  RCK	  protein	  family	  (regulator	  of	  conductance	  of	  K+;	  also	  known	  as	  the	  KTN	  (K+	  transporter,	  nucleotide	  binding	  protein	  family)	  and	  is	  composed	  of	  an	  N-­‐terminal	  RCK_N	  (Pfam02254)	  and	  a	  C-­‐terminal	  RCK_C	  domain	  (Pfam02080;	  FIG.	  3).	  The	  RCK_N	  domain	  was	  previously	  shown	  to	  bind	  nucleotides	   including	   ATP,	   ADP	   or	   NAD+	   and	   NADH,	   however	   c-­‐di-­‐AMP	   binds	  specifically	   to	   the	   C-­‐terminal	   RCK_C	   domain14	   (FIG.	   3).	   It	   is	   thought	   that	  nucleotide	  binding	   to	  KtrA	   leads	   to	   conformational	   changes	  or	   a	   change	   in	   the	  oligomerization	   state	   that	   are	   transduced	   to	   the	   membrane	   transporter	  component	   KtrB	   (FIG.	   4),	   leading	   to	   channel	   opening	   or	   closing.	   KtrASA	   was	  shown	  to	  be	  essential	  for	  the	  growth	  of	  S.	  aureus	  in	  low	  potassium	  conditions14.	  Furthermore,	  gdpP	  mutant	  bacteria	  with	  high	  levels	  of	  c-­‐di-­‐AMP	  are	  sensitive	  to	  salt	  stress	  and	  require,	  similar	  to	  a	  ktrA	  mutant	  strain,	  higher	  levels	  of	  potassium	  for	   growth	   under	   osmotic	   stress	   conditions14,47.	   However,	   additional	  experiments	  are	  needed	  to	  unambiguously	  determine	  how	  binding	  of	  the	  second	  messenger	   c-­‐di-­‐AMP	   to	   KtrA	   affects	   the	   activity	   of	   the	   potassium	   transporter.	  These	   findings	   are	   analogous	   to	   findings	   on	   cAMP/cGMP-­‐gated	   potassium	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channels,	   where	   binding	   of	   these	   nucleotides	   leads	   to	   the	   opening	   of	   the	  channel48.	  	  The	   discovery	   of	   the	   RCK_C	   domain	   as	   a	   c-­‐di-­‐AMP	   receptor	   led	   to	   the	  subsequent	   identification	   of	   the	   S.	   aureus	   cation	   proton	   antiporter	   CpaA	   as	   a	  third	  c-­‐di-­‐AMP	  binding	  protein14	  (FIG.	  3,	  FIG.	  4).	  Even	  though	  the	  RCK_C	  domains	  of	  KtrA	  and	  CpaA	  show	  low	  identity,	  based	  on	  structural	  homology	  models	  they	  are	   likely	   to	   assume	   a	   very	   similar	   fold14.	   As	   CpaA	   is	   also	   a	   predicted	   ion	  transporter	   it	   is	   likely	   to	   be	   involved	   in	   the	   uptake	   of	   potassium	  or	   sodium	   in	  exchange	  for	  an	  intracellular	  proton14.	  	  The	  RCK_C	  domain	  is	  associated	  with	  potassium	  transporters	  or	  channels	  and	   other	   transporters.	   This	   domain	   is	   even	  more	  widely	   distributed	   than	   the	  DAC	  domain	  and	   is	   found	   in	  bacteria,	  archaea	  and	  a	  small	   subset	  of	  eukaryotic	  green	  algae	  where	  the	  DAC	  domain	  is	  absent.	  However,	  organisms	  that	  contain	  a	  DAC	   domain	   usually	   contain	   one	   or	   more	   proteins	   with	   an	   RCK_C	   domain,	  indicating	  that	  c-­‐di-­‐AMP	  might	  regulate	  potassium	  and	  perhaps	  other	  transport	  processes	  in	  a	  variety	  of	  organisms.	  	  	  
Histidine	  kinase	  protein	  KdpD.	  Following	  on	  from	  this,	  a	   further	  c-­‐di-­‐AMP	  target	  protein	  was	  identified	  in	  S.	  aureus	  using	  a	  whole	  genome	  screening	  approach14.	  This	   protein,	   KdpD,	   also	   has	   a	   potential	   role	   in	   potassium	   homeostasis	   and	   in	  addition	   has	   been	   implicated	   as	   a	   regulator	   of	   virulence	   and	   intracellular	  survival	  of	  a	  number	  of	  bacterial	  pathogens49.	  KdpD	  is	  a	  histidine	  kinase	  that	  in	  many	  bacteria,	   together	  with	   its	  cognate	  response	  regulator	  KdpE,	  controls	   the	  expression	   of	   a	   second	   type	   of	   potassium	   uptake	   system	   (FIG.	   3,	   FIG.	   4).	   This	  system	   is,	   in	   contrast	   to	   the	   Ktr	   system,	   an	   ATP-­‐dependent	   potassium	   uptake	  system	  and	  in	  E.	  coli	  consists	  of	  four	  membrane	  components	  KdpFABC.	  The	  two-­‐component	   system	  KdpDE	   is	   required	   for	   the	   expression	  of	  kdpFABC	   at	   a	   very	  low	   potassium	   concentrations	   when	   the	   other	   uptake	   systems	   are	   no	   longer	  sufficient	  for	  adequate	  ion	  uptake45.	  KdpD	  is	  a	  predicted	  membrane	  protein	  with	  N-­‐terminal	   and	   C-­‐terminal	   cytoplasmic	   portions	   containing	   multiple	   domains	  (FIG.	  3).	  The	  protein	  contains	  neither	  an	  RCK_C	  nor	  a	  QacR-­‐like	  domain	  and	  the	  protein	  region	  interacting	  with	  c-­‐di-­‐AMP	  still	  needs	  to	  be	  determined.	  Also,	   the	  role	   of	   the	   Kdp	   system	   in	   potassium	   uptake	   in	   S.	   aureus	   has	   not	   been	   fully	  elucidated	  and	  additional	  work	  is	  needed	  to	  understand	  the	  function	  of	  this	  two-­‐component	  system	  and	  its	  interplay	  with	  cellular	  c-­‐di-­‐AMP	  levels.	  	  Potassium	  transport	  is	  of	  fundamental	  importance	  in	  all	  living	  cells	  and	  in	  bacteria	  has	  essential	  roles	  in	  the	  adaptation	  to	  changes	  in	  osmolarity,	  controls	  the	  activity	  of	   intracellular	  enzymes	  and	  functions	  as	  a	  regulator	  of	   internal	  pH	  and	   in	   the	   maintenance	   of	   an	   appropriate	   membrane	   potential45.	   The	   link	  between	  c-­‐di-­‐AMP	  signaling	  and	   ion	  homeostasis	  may	  therefore	   in	  part	  explain	  why	  this	  nucleotide	  is	  important	  for	  bacterial	  survival.	  	  
PII-­‐like	   signal	   transduction	   protein	   PstA.	   The	   final	   c-­‐di-­‐AMP	   target	   protein,	  identified	  to	  date,	  is	  a	  PII-­‐like	  signal	  transduction	  protein,	  that	  has	  been	  renamed	  PstA14.	   This	   S.	   aureus	   protein	   was	   again	   discovered	   using	   a	   whole	   genome	  screen14.	  PstA	  is	  a	  predicted	  cytoplasmic	  protein	  containing	  a	  DUF970	  domain	  of	  unknown	   function	   (Pfam06153;	   FIG.	   3).	   Structurally	   this	   domain	   resembles	   a	  ferredoxin-­‐like	  alpha/beta	  sandwich,	  which	  is	  also	  found	  in	  the	  cation	  tolerance	  protein	  CutA150	  and	  the	  ATP	  phosphoribosyltransferase	  HisG,	  the	  first	  enzyme	  of	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the	   histidine	   pathway51.	   However	   the	   best	   characterized	   proteins	   with	   this	  structural	   domain	   are	   PII	   nitrogen	   regulatory	   proteins	   belonging	   to	   the	   GlnB	  superfamily.	   These	   are	   key	   signal	   transduction	   proteins	   that	   report	   on	   the	  nitrogen	   and	   carbon	   status	   of	   cells	   by	   sensing	   glutamine	   and	   2-­‐ketoglutarate	  levels52.	  While	  as	  yet	  unconfirmed,	  it	  will	  be	  interesting	  to	  discover	  if	  PstA	  plays	  a	   role	   in	   nitrogen	   regulation	   in	  S.	  aureus	   and	  how	   this	   role	   is	   affected	  by	   c-­‐di-­‐AMP	  levels.	  
	  
Other	  cellular	  processes	  influenced	  by	  c-­‐di-­‐AMP	  levels	  
Cell	  wall	  homeostasis.	   In	   several	   recent	   studies	   alterations	   in	   cellular	   c-­‐di-­‐AMP	  levels	  have	  been	  connected	  to	  changes	  in	  the	  bacterial	  cell	  wall.	  For	  instance,	  S.	  
aureus	  mutants	   lacking	   the	   essential	   cell	   wall	   polymer	   lipoteichoic	   acid	   (LTA)	  regained	   the	   ability	   to	   grow	   almost	   normally	   upon	   inactivation	   of	   GdpP,	   a	  mutation	   that	   leads	   to	   a	   15-­‐fold	   increase	   in	   intracellular	   c-­‐di-­‐AMP	   levels10.	  Furthermore,	   an	   S.	   aureus	   strain	   in	   which	   gdpP	   is	   mutated	   had	   increased	  amounts	  of	  cross-­‐linked	  peptidoglycan,	  which	  was	  hypothesized	  to	  help	  bacteria	  compensate	   for	   the	   lack	   of	   LTA.	   Microscopic	   analysis	   of	   wildtype	   and	   gdpP	  mutant	  strains	  revealed	  a	  13-­‐22%	  reduction	  in	  the	  cell	  size	  of	  S.	  aureus	  cells	  with	  increased	   c-­‐di-­‐AMP	   levels10.	   S.	   aureus,	   B.	   subtilis	   and	   L.	  monocytogenes	   strains	  carrying	   a	  mutated	   gdpP	   display	   increased	   resistance	   to	  ?-­‐lactam	   antibiotics,	  further	  indicating	  that	  changes	  in	  the	  cell	  wall	  have	  occurred	  in	  strains	  with	  high	  c-­‐di-­‐AMP	   levels10,	   16-­‐19,	   40.	   Conversely,	   upon	   overexpression	   of	   GdpP,	   which	  decreases	   c-­‐di-­‐AMP	   levels,	   B.	   subtilis	   and	   L.	   monocytogenes	   become	   highly	  sensitive	   to	   cell	   wall	   targeting	   antibiotics16,	   40.	   Finally	   Lactococcus	   lactis,	   L.	  
monocytogenes	  and	  B.	  subtilis	  gdpP	  mutant	  strains	  are	  more	  resistant	  to	  acid33,	  40,	  53	  and	  heat	  stress47.	  	  Together	   these	   data	   suggest	   that	   c-­‐di-­‐AMP	   is	   involved	   in	   controlling	   S.	  
aureus	   cell	   wall	   synthesis	   and	   cell	   size	   and	   in	   helping	   bacteria	   to	   cope	   with	  membrane	   and	   cell	   wall	   damage,	   acid	   as	   well	   as	   heat	   stress	   (FIG.	   4)	   The	  molecular	  mechanisms	  responsible	   for	  these	  processes	  are	  not	  understood.	  We	  speculate	  that	  several	  of	  these	  phenotypes	  are	  linked	  to	  an	  altered	  ability	  to	  take	  up	   potassium	   under	   varying	   c-­‐di-­‐AMP	   concentrations.	   Potassium	   is	   important	  for	   the	   maintenance	   of	   an	   adequate	   membrane	   potential,	   which	   is	   known	   to	  contribute	   to	   antibiotic	   resistance54,	   55.	   This	   ion	   also	   plays	   a	   crucial	   role	   in	  osmoregulation,	  a	  function	  that	  has	  also	  been	  attributed	  to	  the	  cell	  wall45.	  Lastly,	  potassium	  uptake	   is	   required	   for	   pH	  homeostasis,	   another	   phenotype	   that	   has	  been	  linked	  to	  differences	  in	  c-­‐di-­‐AMP	  levels33.	  	  
Sensing	   of	   DNA	   damage.	  DisA	   is	   an	   octameric	   protein	   that	   binds	   to	   DNA	   as	   a	  single	   focus	   via	   the	   C-­‐terminal	   HhH	   domain	   and	   scans	   the	   chromosome	  while	  synthesizing	  c-­‐di-­‐AMP4,	  5	  (FIG.	  4).	  The	  movement	  of	  the	  DisA	  focus	  is	  dependent	  on	   the	   ability	   of	   the	   protein	   to	   synthesize	   c-­‐di-­‐AMP5,	   8.	   Upon	   detection	   of	  branched	   DNA,	   such	   as	   holliday	   junctions	   or	   stalled	   replication	   forks,	   DisA	  movement	   and	   synthesis	   of	   the	   second	  messenger	   c-­‐di-­‐AMP	   cease4,	   8	   (FIG.	   4).	  This	  decrease	  in	  c-­‐di-­‐AMP	  levels	  is	  believed	  to	  act	  as	  a	  signal	  to	  stop	  replication	  until	  the	  DNA	  can	  be	  repaired,	  potentially	  through	  the	  action	  of	  RadA.	  It	  has	  been	  reported	   that	   DisA	   expression	   increases	   during	   late	   exponential	   phase	   and	  during	  sporulation5.	  This	   results	   in	  a	  3-­‐fold	   increase	   in	  c-­‐di-­‐AMP	   levels	   in	  cells	  that	   are	   undergoing	   sporulation	   as	   compared	   to	   vegetative	   cells8.	   When	   DNA	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damage	  is	  sensed	  by	  DisA	  prior	  to	  the	  onset	  of	  sporulation	  the	  levels	  of	  c-­‐di-­‐AMP	  drop	  resulting	   in	  a	  delay	   in	   the	  onset	  of	  sporulation,	  which	  can	  be	  reversed	  by	  the	  exogenous	  addition	  of	  c-­‐di-­‐AMP8.	  Concurrently,	  expression	  of	  GdpP	  increases	  in	   B.	   subtilis	   cells	   that	   have	   been	   exposed	   to	   a	   DNA-­‐damaging	   agent,	   which	  results	  again	  in	  a	  decline	  in	  c-­‐di-­‐AMP	  levels	  and	  a	  decreased	  sporulation	  rate8.	  In	  this	  way,	   c-­‐di-­‐AMP	   levels	   report	   on	  DNA	   integrity	   and	   in	   this	  manner	  helps	   to	  ensure	  that	  undamaged	  DNA	  is	  packed	  into	  spores	  in	  B.	  subtilis.	  	  	  	  
Induction	  of	  eukaryotic	  host	  cell	  response.	  In	  addition	  to	  its	  functions	  in	  bacterial	  physiology,	   c-­‐di-­‐AMP	   is	   also	   sensed	   by	   eukaryotic	   host	   cells	   and	   has	   been	  recently	  shown	  to	  elicit	  a	  type	  I	  interferon	  response.	  A	  type	  I	  interferon	  response	  is	   a	   well-­‐characterized	   innate	   immune	   response	   leading	   to	   the	   activation	   of	  defense	  mechanisms	  against	  viral	  infection.	  However,	  more	  recently	  it	  has	  been	  recognized	   that	   extracellular	   and	   intracellular	   bacterial	   pathogens	   can	   also	  induce	   a	   type	   I	   interferon	   response	   and	   the	   activator	  molecules	   and	   signaling	  pathways	  responsible	  are	  beginning	   to	  emerge	   (FIG.	  5).	  L.	  monocytogenes	   is	  an	  intracellular	  pathogen,	  which	  after	  entering	  a	  eukaryotic	  host	  cell	  escapes	  from	  the	  vacuolar	  compartment	  and	  resides	  and	  propagates	  within	  the	  cytosol.	  Once	  there,	  the	  cyclic	  dinucleotide	  c-­‐di-­‐AMP	  is	  secreted	  by	  the	  multidrug	  efflux	  pumps	  MdrM	  and	  MdrT,	  the	  expression	  of	  which	  are	  controlled	  by	  the	  regulators	  MarR	  and	   TetR56-­‐58.	   c-­‐di-­‐AMP	   then	   induces,	   like	   its	   counterpart	   c-­‐di-­‐GMP,	   a	   type	   I	  interferon	  response	  leading	  to	  the	  production	  of	  IFN-­‐β (FIG.	  5)6,	  58.	  This	  response	  is	   dependent	   on	   the	  host	   cell	   helicase	  DDX4159,	   as	  well	   as	   the	   transmembrane	  receptor	   STING60,	  61.	   Both	   human	   and	  mouse	   cell	   lines	   depleted	   for	   DDX41	   or	  STING	   as	   well	   as	   STING-­‐knockout	   mice	   or	   mice	   harboring	   a	   loss	   of	   function	  mutation,	   no	   longer	   elicit	   a	   type	   I	   interferon	   response	   during	   infection	  with	  L.	  
monocytogenes59,	   60,	   62.	   An	   interaction	   between	   STING	   and	   c-­‐di-­‐GMP	   has	   been	  reported	  in	  several	  studies61,	  63-­‐66.	  This,	  together	  with	  the	  co-­‐crystal	  structure	  of	  STING	  and	  c-­‐di-­‐GMP63-­‐67,	   identified	  this	  protein	  as	  a	  receptor	   for	  c-­‐di-­‐GMP.	  The	  interaction	  between	  c-­‐di-­‐GMP	  and	  STING	  can	  be	   inhibited	   in	  a	  dose-­‐dependent	  manner	  with	  c-­‐di-­‐AMP,	  suggesting	  that	  STING	  is	  also	  a	  receptor	  for	  c-­‐di-­‐AMP61.	  However,	  very	  recently	  a	  direct	  interaction	  between	  c-­‐di-­‐GMP	  and	  DDX41,	  more	  specifically	   its	   DEAD-­‐box	   domain,	   was	   reported	   and	   c-­‐di-­‐AMP	   was	   also	  demonstrated	  to	  bind	  to	  this	  helicase59.	  Based	  on	  the	  higher	  affinity	  of	  DDX41	  for	  c-­‐di-­‐GMP	   as	   compared	   to	   STING,	   it	   was	   suggested	   that	   DDX41	   is	   the	   actual	  sensor,	   not	   only	   for	   B-­‐DNA	  but	   also	   for	   cyclic	   dinucleotides.	   Cyclic	   nucleotide-­‐bound	   DDX41	   then	   forms	   a	   complex	   with	   STING,	   which	   in	   this	   study	   was	  proposed	  to	  act	  as	  a	  co-­‐receptor59.	  However,	  it	  should	  be	  noted	  that	  as	  of	  yet	  no	  binding	   affinities	   between	   c-­‐di-­‐AMP	   and	   either	   DDX41	   or	   STING	   have	   been	  determined	  and	  further	  work	  is	  needed	  to	  fully	  ascertain	  whether	  c-­‐di-­‐AMP	  is	  a	  biologically	  relevant	  ligand	  for	  either	  of	  these	  eukaryotic	  protein.	  	  Once	  STING	  is	  activated,	  it	  will	  then	  interact	  with	  and	  activate	  the	  kinase	  TBK168.	  This	  in	  turn	  will	   lead	  to	  the	  phosphorylation	  of	  the	  transcription	  factor	  IRF-­‐3	   and	   its	   translocation	   into	   the	   nucleus	   and	   activation	   of	   type	   I	   interferon	  response	   and	   production	   of	   IFN-­‐β	   (FIG.	   5)	  Whether	   this	   is	   advantageous	   to	   L.	  
monocytogenes	   or	   the	   host	   or	   is	   just	   a	   by-­‐product	   of	   the	   bacterium	   regulating	  intracellular	   c-­‐di-­‐AMP	   levels	   by	   transporting	   it	   out	   of	   the	   cell	   remains	   to	   be	  determined.	   Regardless	   if	   beneficial	   or	   detrimental	   to	   the	   bacterium	   MDR	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transporters	  are	  conserved	  among	  bacteria.	  Other	  bacteria	  such	  as	  S.	  aureus	  can	  also	  enter	  the	  host	  cell	  cytosol,	  therefore	  it	  seems	  possible	  that	  c-­‐di-­‐AMP	  is	  also	  secreted	   by	   several	   other	   bacterial	   pathogens,	   potentially	   leading	   to	   immune	  recognition/modulation.	  However,	   the	  matter	   is	   even	  more	   complex,	   as	   it	  was	  recently	  shown	  that	  following	  detection	  of	  foreign	  DNA	  in	  the	  cytosol,	  eukaryotic	  cells	   themselves	   can	   synthesize	   a	   cGAMP	   species69,70.	   This	   eukaryotic	  dinucleotide,	   which	   contains	   a	   2’-­‐5’	   linkage	   and	   hence	   is	   referred	   to	   here	   as	  cGAMP(2’-­‐5’),	   is	   distinct	   from	   the	   bacterial	   dinucleotide	   cGAMP(3’-­‐5’)71-­‐74.	  cGAMP(2’-­‐5’)	  can	  then	  also	  bind	  the	  receptor	  protein	  STING	  to	  activate	  a	  type-­‐I	  IFN	  response	  (FIG.	  5)69-­‐74.	  These	  studies	  have	  also	  shown	  that	  the	  cytosolic	  DNA	  binds	  directly	  to	  the	  eukaryotic	  cGAMP	  synthase	  (cGAS)	  and	  stimulates	  enzyme	  activity,	  leading	  to	  the	  production	  of	  cGAMP(2’-­‐5’)8472,	  73.	  Once	   cyclic	   dinucleotides	   were	   recognized	   as	   immunomodulatory	   and	  immune	   stimulatory	   molecules,	   this	   prompted	   further	   research	   into	   their	  potential	   use	   as	   vaccine	   adjuvants.	   There	   are	   now	   several	   promising	   reports	  describing	   a	   beneficial	   effect	   for	   c-­‐di-­‐GMP	   and	   c-­‐di-­‐AMP	   as	   adjuvant	   for	   both	  mucosal	   and	   systemic	   vaccination,	   highlighting	   another	   potential	   use	   for	   these	  molecules	  75-­‐78.	  	  	  
Unresolved	  questions	  Since	  the	  discovery	  of	  c-­‐di-­‐AMP	  in	  a	  structural	  study	  in	  2008,	   its	  existence	   in	  several	  bacteria	  has	  now	  been	  confirmed	  experimentally.	  Based	  on	  the	  many	  phenotypes	  associated	  with	  altered	  c-­‐di-­‐AMP	  levels,	  there	  is	  no	   longer	   a	   doubt	   that	   this	   molecule	   plays	   an	   important	   role	   as	   second	  messenger	   and	   the	   first	   target	   proteins	   and	   cellular	   pathways	   controlled	   by	   it	  have	   now	   been	   identified	   (FIG.	   4).	   Despite	   these	   advances,	   there	   are	   many	  outstanding	   questions.	   Firstly,	   in	   the	   majority	   of	   microorganisms,	   c-­‐di-­‐AMP	  production	   is	  only	   inferred	  based	  on	  the	  occurrence	  of	  DAC	  domain-­‐containing	  proteins	   and	   remains	   to	   be	   confirmed.	   Likewise	   the	   corresponding	   c-­‐di-­‐AMP	  degrading	  enzymes	  need	  to	  be	  identified	  in	  bacteria	  outside	  the	  Firmicutes	  and	  in	   archaea.	   Currently	   only	   one	   signal,	  DNA	  damage	  has	  been	  directly	   linked	   to	  changes	   in	   c-­‐di-­‐AMP	   levels4,	  5,8.	   However,	   it	   can	   be	   expected	   that	   other	   signals	  will	   affect	   c-­‐di-­‐AMP	   synthesis	   especially	   in	   those	   organism	   lacking	   DisA	  homologues	  (FIG.	  4).	  But	  the	  focus	  of	  most	  research	  is	  on	  identifying	  other	  c-­‐di-­‐AMP	   receptor	   and	   effector	   proteins.	   Based	   on	   the	   observation	   that	   most	  organisms	  contain	  only	  a	  single	  DAC	  enzyme,	  the	  c-­‐di-­‐AMP	  network	  appears	  to	  be	  much	   simpler	   than	   the	   c-­‐di-­‐GMP	   signaling	   network	  where	   organisms	   often	  contain	  more	  than	  twenty	  enzymes	  involved	  in	  the	  synthesis	  or	  hydrolysis	  of	  this	  second	   messenger.	   Therefore,	   one	   may	   not	   expect	   to	   find	   as	   many	   receptor	  proteins	   and	   induction	   signals	   as	   for	   c-­‐di-­‐GMP,	  however	   it	   seems	   likely	   that	   in	  addition	  to	  the	  targets	  described	  here,	  other	  protein	  will	  able	  to	  bind	  c-­‐di-­‐AMP	  in	  order	   to	   explain	   all	   the	   observed	   phenotypes.	   This	   would	   be	   similar	   to	   the	  “simpler”	  cAMP	  and	  ppGpp	  signaling	  systems,	  which	  despite	  the	  limited	  number	  of	  turnover	  enzymes,	  function	  through	  several	  different	  effector	  proteins	  and	  are	  of	   very	   broad	   physiological	   impact1,	  2.	   Recently,	   novel	   tools	   such	   as	   chemically	  modified	   nucleotide	   analogues	   that	   can	   be	   used	   in	   combination	  with	   sensitive	  mass	   spectrometry	   methods	   for	   the	   capturing	   and	   identification	   of	   receptor	  proteins	  and	  a	  new,	  simple	  and	   fast	  binding	  assay	  suitable	   for	  high	  throughput	  screening	  assays,	  have	  been	  developed79,	  80.	  This	  will	  make	  the	  rapid	  discovery	  of	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additional	  c-­‐di-­‐AMP	  receptor	  proteins	  possible	  and	  guarantee	  an	  exciting	  future	  for	  this	  field.	  	  
Key	  points	  	  	  
• When	  faced	  with	  stresses	  in	  a	  rapidly	  changing	  environment,	  bacteria	  must	  be	  able	  to	  sense	  these	  changes	  and	  coordinate	  responses	  rapidly.	  To	  do	  this	  they	  employ	  a	  number	  of	  nucleotide	  signaling	  molecules	  that	  act	  as	  second	  messengers	  to	  transduce	  signals	  around	  the	  cell.	  
• Cyclic	  diadenosine	  monophosphate	  (c-­‐di-­‐AMP)	  is	  a	  recently	  discovered	  signaling	  nucleotide	  that	  is	  present	  in	  many	  Gram-­‐positive	  bacteria,	  a	  limited	  number	  of	  Gram-­‐negative	  species	  and	  likely	  also	  some	  archaea.	  	  
• This	  signaling	  molecule	  is	  synthesized	  by	  cyclase	  enzymes,	  which	  condense	  two	  molecules	  of	  ATP	  to	  c-­‐di-­‐AMP	  using	  the	  enzymatic	  activity	  that	  is	  contained	  within	  the	  DisA_N	  domain,	  a	  domain	  that	  is	  distinct	  from	  other	  cyclic	  dinucleotide	  cyclase	  domains.	  
• c-­‐di-­‐AMP	  is	  degraded	  to	  the	  linear	  molecule	  pApA	  by	  the	  action	  of	  phosphodiesterases	  containing	  a	  DHH/DHHA1	  domain	  architecture.	  
• Once	  synthesized,	  this	  molecule	  binds	  to	  a	  specific	  set	  of	  receptor	  or	  target	  proteins	  and	  allosterically	  alters	  their	  function	  or	  the	  function	  of	  downstream	  effector	  proteins.	  To	  date	  five	  c-­‐di-­‐AMP	  receptor	  proteins	  have	  been	  identified,	  namely	  DarR,	  which	  is	  involved	  in	  the	  regulation	  of	  fatty	  acid	  synthesis	  in	  Mycobacterium	  smegmatis,	  KtrA,	  CpaA	  and	  KdpD,	  which	  are	  all	  potentially	  linked	  to	  potassium	  or	  ion	  transport	  in	  
Staphylococcus	  aureus	  and	  PstA,	  a	  receptor	  of	  unknown	  function.	  	  
• Although	  the	  exact	  pathways	  have	  yet	  to	  be	  fully	  worked	  out,	  a	  number	  of	  phenotypes	  associated	  with	  altered	  c-­‐di-­‐AMP	  levels	  in	  the	  cell	  have	  now	  been	  characterized.	  For	  instance	  c-­‐di-­‐AMP	  is	  linked	  to	  the	  sensing	  of	  DNA	  integrity	  in	  Bacillus	  subtilis,	  and	  to	  cell	  wall	  homeostasis	  in	  multiple	  species	  and	  can	  also	  induce	  a	  eukaryotic	  immune	  response	  when	  secreted	  by	  the	  bacterium	  Listeria	  monocytogenes.	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Box	  1:	  c-­‐di-­‐GMP	  signaling	  in	  bacteria	  Cyclic	   di-­‐guanosine	   monophosphate	   (c-­‐di-­‐GMP)	   is	   a	   well-­‐studied	   bacterial	  secondary	  messenger	   that	  was	   first	   discovered	   in	   1987	  by	  work	   performed	   in	  the	   lab	   of	   Moshe	   Benziman,	   where	   it	   was	   shown	   to	   activate	   cellulose	  biosynthesis	   in	  Gluconacetobacter	  xylinus81.	  c-­‐di-­‐GMP	  homeostasis	   in	   the	   cell	   is	  controlled	   by	   the	   opposing	   actions	   of	   diguanylate	   cyclases	   (DGCs)	   and	  phosphodiesterases	   (PDEs)3,	   36,	   82.	   Signal-­‐dependent	   dimerization	   of	   GGDEF	  domain-­‐containing	   DGCs,	   each	   bound	   to	   one	   molecule	   of	   GTP,	   results	   in	   the	  activation	  of	  cyclase	  activity	  and	  the	  condensation	  of	  the	  two	  GTP	  molecules	  to	  form	   c-­‐di-­‐GMP36.	   The	   dinucleotide	   is	   degraded	   by	   PDE	   enzymes,	   which	   are	  characterized	   by	   the	   presence	   of	   EAL	   or	   HD-­‐GYP	   domains36.	   While	   the	   vast	  majority	  of	  signals	  that	  regulate	  the	  activity	  of	  c-­‐di-­‐GMP	  DGCs	  and	  PDEs	  remain	  to	  be	  established,	   a	  number	  of	   environmental	  queues	   such	  as	   light83,	   oxygen84,	  nutrient	   starvation85,	   the	  presence	  of	   antibiotics86	   and	   redox	   state87	  have	  been	  shown	  to	  affect	  their	  activity	  (reviewed	  in3,	  82).	  Furthermore,	  indirect	  activation	  of	   c-­‐di-­‐GMP	   synthesizing	  or	  degrading	  proteins	  by	  phosphotransfer	   systems	   in	  response	   to	   environmental	   changes	   have	   been	   described	   in	   several	   bacteria	  where	  GGDEF	  or	  EAL	  domain-­‐containing	  proteins	  contain	  an	  N-­‐terminal	  receiver	  (REC)	  domain	  that	  is	  phosphorylated	  by	  cognate	  senor	  kinases88,	  89.	  	  Once	  synthesized,	  c-­‐di-­‐GMP	  binds	  to	  receptor	  proteins,	  allosterically	  affects	  their	   activity	   and	   in	   this	   manner	   modulates	   specific	   cellular	   pathways.	   The	  phenotype	  most	   frequently	   associated	  with	   an	   increase	   in	   c-­‐di-­‐GMP	   levels	   is	   a	  switch	  from	  a	  motile	  to	  a	  biofilm-­‐associated	  lifestyle82.	  Other	  outputs	  linked	  with	  alterations	   in	   cellular	   c-­‐di-­‐GMP	   levels	   include	   changes	   in	   virulence	   related	  properties	   and	   a	   regulation	   of	   the	   bacterial	   cell	   cycle3,	  82,	  90.	   A	   large	   number	   of	  receptor	   proteins	   involved	   in	   controlling	   these	   phenotypes	   have	   now	   been	  identified	   and	   these	   fall	   into	   four	   different	   classes90.	   PilZ	  was	   the	   first	   domain	  shown	   to	   bind	   c-­‐di-­‐GMP81,	  91	   and	   is	   present	   in	   proteins	   frequently	   involved	   in	  regulating	   motility	   and	   the	   production	   of	   cellulose	   and	   alginate81,92.	   A	   second	  class	   of	   c-­‐di-­‐GMP	   receptor	   proteins	   are	   GGDEF	   or	   EAL	   domain-­‐containing	  proteins	  possessing	  a	  degenerate	  active	  site.	  While	  these	  proteins	  are	  no	  longer	  capable	   of	   synthesizing	   or	   degrading	   c-­‐di-­‐GMP,	   they	   can	   still	   bind	   the	  dinucleotide	  and	  thus	  translocate	  the	  signal	  within	  the	  protein93,	  94.	  A	  third	  type	  of	   c-­‐di-­‐GMP	   receptor	   includes	   transcription	   factors	   such	   as	   FleQ,	   a	   master	  regulator	   of	   flagellar	   gene	   expression	   in	   Pseudomonas	   aeruginosa39.	   The	   final	  class	   of	   receptors	   are	   riboswitches,	   small	   mRNA	   segments	   present	   in	   the	  upstream	  untranslated	  region	  of	  some	  genes.	  Binding	  of	  c-­‐di-­‐GMP	  to	  this	  mRNA	  region	   regulates	   the	   transcription	   or	   translation	   of	   the	   downstream	   gene95.	  Although	  much	  about	  c-­‐di-­‐GMP	  remains	  to	  be	  uncovered,	  the	  multiplicity	  of	  c-­‐di-­‐GMP	   DGCs	   and	   PDEs	   encoded	   in	   bacterial	   genomes,	   in	   proteobacteria	   in	  particular,	   highlights	   the	   importance	   of	   this	   secondary	   messenger	   in	   enabling	  bacteria	   to	   switch	   between	   different	   lifestyles	   depending	   on	   specific	  environmental	  cues.	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Box	  2:	  Potential	  c-­‐di-­‐AMP	  cyclases	  and	  hydrolases	  in	  archaea.	  	  Based	  on	  bioinformatics	  analysis	  and	  the	  occurrence	  of	  DAC	  domain-­‐containing	  proteins	  it	  is	  likely	  that	  c-­‐di-­‐AMP	  is	  also	  produced	  by	  a	  subset	  of	  archaea12.	  Here,	  the	  DAC	  domain	   is	   found	  primarily	   in	   cytoplasmic	  proteins	  with	   a	   stand-­‐alone	  DAC	  domain.	  This	  architecture	  might	  suggest	  that	  these	  cyclases	  cannot	  directly	  sense	   environmental	   or	   cellular	   changes	   and	   instead	   need	   a	   separate	   sensory	  protein.	  Aside	  from	  the	  stand-­‐alone	  DAC	  domain	  proteins,	  the	  DAC	  domain	  is,	  in	  several	   cases,	   fused	   to	   a	   domain	   annotated	   as	   a	   pyruvate	   kinase	   C-­‐terminal	  alpha/beta	  C	  domain	   (PK_C;	  Pfam02887).	  Pyruvate	  kinase	  enzymes	  are	  central	  metabolic	   enzymes	   involved	   in	   glycolysis.	   They	   are	   homotetrameric	   enzymes,	  which	  in	  bacteria	  and	  archaea	  consist	  of	  three	  domains	  (A,	  B,	  and	  C).	  While	  the	  active	  site	  is	  located	  in	  the	  interface	  between	  domains	  A	  and	  B,	  the	  PK_C	  domain	  can	  serve	  as	  the	  binding	  site	  for	  an	  allosteric	  effector96.	  It	  is	  therefore	  plausible	  that	   the	   PK_C	   domain	   in	   these	   archaeal	   proteins	   serves	   as	   a	   small	   molecule-­‐binding	   domain,	  which	   in	   turn	   regulates	   the	   cyclase	   activity.	   Furthermore,	   the	  cyclase	  domain	  is	  also	  found	  in	  association	  with	  PAS,	  polycystic	  kidney	  disease	  I	  (PKD;	  Pfam00801)	  or	  TPR	  domains.	  These	  three	  domains	  have	  been	  implicated	  as	   ligand	   binding	   or	   protein-­‐protein	   interaction	   domains	   and	   therefore	   might	  serve	  to	  regulate	  the	  activity	  of	  the	  associated	  DAC	  domain	  upon	  ligand	  binding	  (Figure	  Box	  2).	  While	  c-­‐di-­‐AMP	  production	  by	  archaea	  has	  yet	   to	  be	  confirmed	  experimentally,	   the	   DAC	   domains	   in	   these	   organisms	   have	   the	   conserved	  DGA	  amino	   acid	   signature	   and	   a	   conserved	   RH	   in	   place	   of	   the	   RHR	  motif	   found	   in	  active	   cyclases	   and	   it	   is	   therefore	   proposed	   that	   these	   enzymes	   are	   renamed	  DacV-­‐	  DacZ	  (Table	  S1	  and	  Figure	  Box	  2).	  	  No	   homologues	   of	   the	   c-­‐di-­‐AMP-­‐degrading	   enzyme	  GdpP	   are	   present	   in	  archaea.	   However,	   proteins	   belonging	   to	   a	   different	   family	   of	   DHH/DHHA1	  domain-­‐containing	   proteins	   could	   serve	   this	   function.	   Interestingly	   candidates	  for	  c-­‐di-­‐AMP	  PDEs	  in	  archaea	  are	  proteins	  with	  a	  TrkA_N–DHH/DHHA1	  domain	  structure.	   These	   proteins	   co-­‐occur	   in	   species	   containing	   DAC	   domain	   proteins	  and	   the	   TrkA_N	   domain,	   which	   is	   also	   referred	   to	   as	   an	   RCK_N	   (regulator	   of	  conductance	  of	  K+)	  domain,	  is	  associated	  with	  potassium	  or	  other	  transporters,	  a	  cellular	   pathway	   that	   has	   been	   linked	   to	   the	   c-­‐di-­‐AMP	   signaling	   network	   in	  bacteria	  as	  we	  will	  discuss	  later.	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  FIGURE	   Box	   2:	  Architecture	   of	   DAC	   domain-­‐containing	   proteins	   and	   potential	   c-­‐di-­‐AMP	  
hydrolases	   in	   archaea.	   Of	   the	   65	   proteins,	   most	   either	   do	   not	   contain	   any	   recognizable	  associated	  domain	  or	  a	  pyruvate	  kinase	  C-­‐terminal	  alpha/beta	  C	  (PK_C)	  domain,	  which	  together	  represent	   93.9%	  of	   all	   archaeal	   DAC	   domain-­‐containing	   proteins	   (red	   box).	   For	   the	   remaining	  four	  archaeal	  proteins	  the	  DAC	  domain	  is	  associated	  twice	  with	  PAS	  domains	  and	  once	  each	  with	  extracellularly	  located	  tetricopeptide	  repeat	  (TPR)	  or	  polycystic	  kidney	  disease	  I	  (PKD)	  domains.	  Candidates	   for	   c-­‐di-­‐AMP	   phosphodiesterases	   in	   archaea	   are	   proteins	   with	   a	   TrkA_N–DHH/DHHA1	   domain	   structure.	   These	   proteins	   co-­‐occur	   in	   species	   containing	   DAC	   domain	  proteins	  and	  the	  TrkA_N	  domain,	  otherwise	  known	  as	  an	  RCK_N	  domain.	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  FIGURE	  1:	  c-­‐di-­‐AMP	  production.	  c-­‐di-­‐AMP	  is	  synthesized	  by	  the	  condensation	  of	  two	  molecules	  of	  ATP	  by	  diadenylate	   cyclase	   (DAC)	   enzymes	   (blue).	  DacA,	  DisA	   and	  DacB	   are	   the	   three	  most	  prevalent	  bacterial	  cyclases	  that	  have	  been	  shown	  to	  be	  active	  in	  vitro	  or	  in	  vivo.	  c-­‐di-­‐AMP	  is	  then	  degraded	  to	  pApA	  by	  the	  action	  of	  phosphodiesterases	  (PDEs)	  (red).	  GdpP	  is	  currently	  the	  only	  characterized	  c-­‐di-­‐AMP	  PDE.	  Next,	  it	  is	  assumed	  that	  c-­‐di-­‐AMP	  binds	  to	  a	  specific	  set	  of	  receptor	  or	   target	   proteins,	   which	   in	   turn	   affect	   the	   activity	   of	   effector	   proteins	   and	   in	   this	   manner	  contribute	  to	  the	  regulation	  of	  specific	  cellular	  pathways.	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  FIGURE	  2:	  Domain	  architecture	  of	  known	  and	  predicted	  bacterial	  c-­‐di-­‐AMP	  synthases	  and	  
hydrolases.	  Currently	  1887	  bacterial	  DAC	  domain-­‐containing	  sequences	  are	   listed	   in	   the	  Pfam	  database.	   The	   three	   most	   abundant	   ones	   are	   DacA	   (69.1%),	   DisA	   (24.1%)	   and	   DacB	   (5.5%),	  which	   together	   represent	   98.7%	   of	   the	   total	   DAC	   domain-­‐containing	   proteins	   in	   bacteria	   (red	  box).	  DisA	  is	  associated	  with	  a	  HhH	  domain,	  DacA	  with	  a	  transmembrane	  domain	  and	  DacB	  with	  a	  YojJ	  domain.	  The	  rarer	  DAC	  domain-­‐containing	  proteins	  (DacC,	  DacD,	  DacE	  and	  DacF)	  contain	  DAC	   domains	   associated	   with	   a	   YbbR	   domain,	   a	   phosphoenolpyruvate-­‐dependent	   sugar	  phosphotransferase	  system	  EIIA	  domain,	  a	  tetricopeptide	  repeat	  (TPR)	  domain,	  and	  a	  domain	  of	  unknown	   function	   (DUF4062),	   respectively	   (associated	  domains	   in	  orange).	  Bacterial	   c-­‐di-­‐AMP	  phosphodiesterases	  with	  homology	  to	  GdpP	  are	  only	  found	  in	  the	  Firmicutes	  and	  Tenericutes.	  In	  other	  phyla,	   it	   is	  possible	  that	  the	  DHH	  and	  DHHA1	  domains	  are	  associated	  with	  other	  sensory	  domains	  or	  that	  a	  different	  class	  of	  enzyme	  is	  responsible	  for	  c-­‐di-­‐AMP	  hydrolysis	  (red	  enzyme).	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  FIGURE	  3:	  c-­‐di-­‐AMP	   receptor	   proteins.	   a)	  Schematic	   representation	  of	   the	  M.	  smegmatis	  c-­‐di-­‐AMP	  receptor	  protein	  DarR.	  DarR	  is	  a	  cytoplasmic	  transcription	  factor	  with	  a	  DNA-­‐binding	  HTH	  domain	   and	   a	   C-­‐terminal	   QacR-­‐like	   domain.	   The	   c-­‐di-­‐AMP	   binding	   domain	   has	   not	   yet	   been	  identified.	   b)	   Schematic	   representation	   of	   the	   S.	   aureus	   c-­‐di-­‐AMP	   receptor	   protein	   KtrA,	   a	  cytoplasmic	  gating	  component	  of	  the	  Ktr-­‐type	  potassium	  transport	  system.	  KtrA	  is	  composed	  of	  an	  N-­‐terminal	  RCK_N	  domain	  indicated	  in	  blue	  and	  a	  C-­‐terminal	  RCK_C	  domain	  shown	  in	  orange.	  The	  RCK_N	  domain	   is	  known	   to	  bind	  ATP,	  ADP,	  NAD+	  and	  NADH,	  while	   the	  RCK_C	  domain	  has	  recently	   been	   shown	   to	   interact	   with	   c-­‐di-­‐AMP.	   Ktr-­‐type	   potassium	   transport	   systems	   are	  composed	  of	   a	  KtrB-­‐type	  membrane	  protein	   and	   the	   cytoplasmic	  KtrA-­‐type	   gating	   component.	  Binding	   of	   c-­‐di-­‐AMP	   to	   the	   gating	   component	  KtrA	   has	   been	   suggested	   to	   result	   in	   changes	   in	  potassium	  transport	  activity.	  c)	  Schematic	  representation	  of	  S.	  aureus	  c-­‐di-­‐AMP	  receptor	  protein	  CpaA.	   CpaA	   is	   a	   predicted	   K+	   or	   Na+	   antiporter	   protein	   and	   consists	   of	   an	   N-­‐terminal	  transmembrane	   domain	   (yellow),	   followed	   by	   a	   cytoplasmically	   located	   RCK_N	   (blue)	   domain	  and	  the	  c-­‐di-­‐AMP	  binding	  RCK_C	  (orange)	  domain.	  d)	  Illustration	  of	  the	  two-­‐component	  system	  KdpDE,	  known	  to	  be	   involved	   in	  K+	  uptake	   in	  E.	  coli.	  KdpD	  is	  a	  histidine	  sensor	  kinase	  that	  has	  been	  shown	  to	  bind	  to	  c-­‐di-­‐AMP	  in	  S.	  aureus.	  This	  protein	  is	  responsible	  for	  phosphorylating	  the	  response	  regulator	  KdpE.	  The	  cytoplasmic	  regions	  of	  KdpD	  contain	  multiple	  domains	  and	  it	  is	  not	  yet	   known	   which	   one	   binds	   c-­‐di-­‐AMP.	   e)	   Schematic	   illustration	   of	   the	   S.	   aureus	   cytoplasmic	  protein	  PstA,	  which	  binds	  c-­‐di-­‐AMP	  and	  may	  be	  involved	  in	  nitrogen	  regulation.	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  FIGURE	  4:	  The	   c-­‐di-­‐AMP	   signaling	   network.	   For	  both	  S.	  aureus	   and	  B.	  subtilis	   environmental	  changes	  (lightening	  bolt)	  are	  potentially	  sensed	  by	  the	  sensory	  domains	  associated	  with	  YbbR	  or	  by	  other	  as	  of	  yet	  unidentified	  mechanisms.	  YbbR	  has	  been	  shown	  to	  interact	  with	  DacA	  resulting	  in	   an	   increase	   in	   cyclase	   activity	   and	   c-­‐di-­‐AMP	   synthesis15.	   To	   date	   four	   c-­‐di-­‐AMP	   receptor	  proteins	  have	  been	  identified	  in	  S.	  aureus;	  the	  potassium	  transporter	  gating	  component	  KtrA,	  the	  ion	   transporter	   CpaA,	   the	   two-­‐component	   sensor	   kinase	   KdpD	   and	   the	   hypothetical	   protein	  PstA14.	   In	   the	   case	   of	   CpaA,	   c-­‐di-­‐AMP	   binding	   is	   thought	   to	   directly	   affect	   ion	   transport.	   KtrA	  interacts	  with	   the	  effector	  protein	  KtrB,	   a	  membrane	   component	   responsible	   for	   the	  uptake	  of	  potassium.	   It	   is	   thought	   that	   nucleotide	   binding	   to	   KtrA	   leads	   to	   conformational	   changes	   or	   a	  change	  in	  the	  oligomerization	  state	  that	  are	  transduced	  to	  the	  membrane	  transporter	  component	  KtrB	   resulting	   in	   a	   change	   in	   potassium	   uptake	   activity14.	   KdpD	   phosphorylates	   the	   response	  regulator	  KdpE	  to	  effect	  changes	  in	  the	  cell.	  The	  function	  of	  PstA	  is	  unknown14.	  Based	  on	  in	  vitro	  activity	  data	  it	  is	  thought	  that	  the	  c-­‐di-­‐AMP-­‐specific	  phosphodiesterase	  GdpP	  senses	  intracellular	  heme	   through	   an	   interaction	  with	   the	   PAS	   domain,	   resulting	   in	   decreased	   PDE	   activity,	   while	  nitric	  oxide	  (NO)	  binding	  to	  heme	  results	  in	  an	  increase	  in	  PDE	  activity	  and	  potentially	  a	  decrease	  in	  c-­‐di-­‐AMP	  concentration35.	  B.	  subtilis	  has	  two	  additional	  c-­‐di-­‐AMP	  cyclases,	  DisA	  and	  DacB.	  The	  sensory	   function	   of	   DisA	   is	   the	   best	   characterized.	   This	   protein	   binds	   via	   its	   associated	   HhH	  domain	   to	   DNA	   and	   upon	   detection	   of	   branched	   DNA	   c-­‐di-­‐AMP	   synthesis	   stops	   and	   cellular	  nucleotide	  levels	  drop4,	  5.	  DacB	  has	  an	  associated	  cytoplasmic	  YojJ	  domain	  that	  may	  be	  involved	  in	   sensing	   as	   of	   yet	   unknown	   intracellular	   signals	   and	   based	   on	   expression	   data	   it	   has	   been	  suggested	  that	  DacB	  is	  active	  during	  sporulation32.	  In	  M.	  smegmatis	  c-­‐di-­‐AMP	  is	  synthesized	  by	  a	  DisA	   protein	   and	   has	   been	   demonstrated	   to	   bind	   to	   the	   transcriptional	   repressor	   DarR	   and	  increase	   association	   of	  DarR	  with	   the	   promoter	   regions	   of	   three	   genes,	   the	   cold	   shock	  protein	  
cspA,	   a	   medium-­‐chain	   fatty	   acyl-­‐CoA	   ligase	   and	   a	   major	   facilitator	   family	   transporter13.	   In	   all	  cases,	   it	   is	   assumed	   that	  at	  high	  c-­‐di-­‐AMP	   levels	   the	  nucleotide	  will	  bind	   to	   these	  or	  other	   still	  unknown	  receptor	  proteins	  (orange)	  and	  in	  doing	  so	  allosterically	  modify	  their	  function.	  In	  this	  way,	   changes	   in	   c-­‐di-­‐AMP	   levels	   affect	   ion	   transport,	   cell	   wall	   homeostasis,	   DNA	   integrity	   and	  through	  DacB	  perhaps	  function	  in	  the	  sporulation	  processes	  in	  B.	  subtilis	  as	  well	  as	  in	  membrane	  homeostasis	  as	  suggested	  for	  M.	  smegmatis.	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  FIGURE	  5:	  Induction	  of	  a	  type	  I	  interferon	  response	  by	  bacteria.	  Recognition	  of	  extracellular	  bacteria	  occurs	  through	  pathogen-­‐associated	  molecular	  patterns	  (PAMPs)	  such	  as	  LPS	  or	  DNA	  by	  host	   pattern	   recognition	   receptors	   (PRRs)97.	   This	   recognition	   leads	   to	   activation	   of	   the	   kinase	  TBK1	   through	   the	   MyD88	   or	   TRIF	   pathways98.	   Activated	   TBK1	   in	   turn	   phosphorylates	   IRF-­‐3,	  resulting	   in	   its	   translocation	  across	   the	  nuclear	  membrane	  and	   induction	  of	  a	   type	   I	   interferon	  response68.	   On	   the	   other	   hand,	   the	   intracellular	   bacterial	   pathogen	   L.	   monocytogenes	   enters	  eukaryotic	   host	   cells	   and	   is	   initially	   contained	   within	   a	   vacuolar	   compartment.	   However,	   L.	  
monocytogenes	   can	   escape	   from	   the	   vacuole	   and	   enter	   the	   cytosol	   where	   some	   of	   the	   cyclic	  dinucleotide	   c-­‐di-­‐AMP	   pool	   is	   secreted6.	   Next,	   c-­‐di-­‐AMP	   is	   thought	   to	   bind	   to	   the	   eukaryotic	  helicase	  DDX41	  which	   in	   turn	   interacts	  with	   the	  co-­‐receptor	  STING59.	  Alternatively,	   it	  has	  been	  suggested	   that	   c-­‐di-­‐AMP	   directly	   interact	   with	   the	   cytosolic	   portion	   of	   the	   receptor	   protein	  STING60-­‐66,	   which	   upon	   nucleotide	   binding	   becomes	   activated	   and	   can	   then	   interact	   with	   and	  activate	   the	   kinase	   TBK168.	   This	   will	   again	   lead	   to	   phosphorylation	   and	   translocation	   of	   the	  transcription	  factor	  IRF-­‐3	  and	  activation	  of	  type	  I	   interferon	  response	  and	  production	  of	   IFN-­‐β.	  STING	  is	  also	  the	  receptor	  for	  cyclic	  c-­‐di-­‐GMP	  and	  can	  additionally	  be	  activated	  by	  dsDNA	  and	  the	  eukaryotic	   cyclic	   dinucleotide	   cGAMP(2’-­‐5’)82,69,	  70,68,	  71-­‐74,	  99.	   cGAMP(2’-­‐5’)	   is	   a	   eukaryotic	   cyclic	  dinucleotide	  synthesized	  by	  the	  cytoplasmic	  synthase	  cGAS	  in	  response	  to	  the	  sensing	  of	  DNA	  in	  the	  cell.	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   DAC	  (1887)	   PDE	  
Associated	  domain	   	   	  
DisA_N	  
linker/HhH	   YojJ	   YbbR	   PTS_EIIA_2	   TPR	  
DUF
4062	  
	  Proposed	  protein	  name	   YbbR*	   DacA	   DisA	   DacB	   DacC	   DacD	   DacE	   DacF	   GdpP	  
Number	  of	  proteins	   	   1304	   454	   104	   16	   6	   2	   1	   	  
Phylum	  (number	  of	  DAC	  domains)**	   	   	   	   	   	   	   	   	   	  Cyanobacteria	  (65)	  
	  
X	  
	   	   	   	   	   	   	  Fusobacteria	  (25)	  
	   	  
X	  
	   	   	   	   	   	  Deferribacteres	  (3)	   X	   X	  
	   	   	   	   	   	   	  Proteobacteria	  (95)	  
	   	   	   	   	   	   	   	   	  Deltaproteobacteria	   X	   X	  
	   	  
11	  
	   	   	   	  Lentisphaerae	  (2)	   X	   X	  
	   	   	   	   	   	   	  Spirochaetes	  (47)	   X	  	   X	  
	   	   	  
1	  
	   	   	  Synergistetes	  (7)	   X	   X	  
	   	   	   	   	   	   	  Deinococcus-­‐Thermus	  (13)	   X	   X	  
	   	   	   	   	   	   	  Verrucomicrobia	  (8)	   x	   X	  
	   	   	  
4	  
	   	   	  Dictyoglomi	  (2)	  
	   	  
X	  
	   	   	   	   	   	  Bacteroidetes	  (129)	   X	   X	  
	   	   	   	   	   	   	  Chlamydiae	  (27)	  
	  
X	  
	   	   	   	   	   	   	  Thermotogae	  (12)	  
	   	  
X	  
	   	   	   	   	   	  Acidobacteria	  (4)	   x	   X	  
	   	   	   	   	   	   	  Nitrospirae	  (4)	   x	   X	  
	   	   	   	   	   	   	  Aquificae	  (12)	   x	   X	  
	   	   	   	   	   	   	  Actinobacteria	  (228)	  
	   	  
X	  
	   	   	   	   	   	  Streptomyces	  spp.	  
	   	  
X	  
	   	   	   	   	   	  Corynebacterium	  spp.	  
	   	  
x	  
	   	   	   	   	   	  Mycobacterium	  spp.	  
	   	  
X	  
	   	   	   	   	   	  Propionibacterium	  spp.	  
	   	  
X	  
	   	   	   	   	   	  Actinomyces	  spp.	  	  
	   	  
X	  
	   	   	  
1	  
	   	  	  	  
	   	   	   	   	   	   	   	   	  Planctomycetes	  (10)	   x	   X	  
	   	   	  
1	  
	   	   	  Chloroflexi	  (11)	   X	   X	  
	   	   	   	   	   	   	  Firmicutes	  (1139)	   X	   X	   X	  
	   	   	   	   	   	  Clostridium	  spp.	   X	   X	   X	   1	   1	  
	  
1	   1	   X	  
Lactobacillus	  spp.	   X	   X	  
	   	   	   	   	   	  
X	  
Streptococcus	  spp.	   X	   X	  
	   	  
4	  
	   	   	  
X	  
Lactococcus	  spp.	   X	   X	  
	   	   	   	   	   	  
X	  
Enterococcus	  spp.	   X	   X	  
	   	   	   	   	   	  
X	  
Staphylococcus	  spp.	   X	   X	  
	   	   	   	   	   	  
X	  
Bacillus	  spp.	   X	   X	   X	   X	  
	   	   	   	  
X	  
Listeria	  spp.	   X	   X	  
	   	   	   	   	   	  
X	  
Negativicutes	   X	   X	   X	  
	   	   	   	   	  
X	  
Erysipelotrichi	   X	   X	  
	   	   	   	   	   	  
X	  Tenericutes	  (33)	  
	  
X	  





	   DAC	  (65)	   PDE	  
Associated	  domain	   	   none	  	   PK_C	   PAS	   TPR	   PKD	  
	   	  
TrkA_N/	  
DHH/DHHA1	  
Proposed	  protein	  name	   	   DacZ	   DacY	   DacX	   DacW	   DacV	  
	   	   	  Euryarchaeota	  (65)	   	   49	   12	   2	   1	   1	  
	   	  
58	  *X	  =	  number	  of	  YbbR	  domains	  is	  the	  same	  or	  greater	  than	  the	  number	  of	  DAC	  domains	  within	  the	  phylum;	  X	  =	  number	  of	  YbbR	  domains	  is	  at	  least	  half	  of	  the	  number	  of	  DAC	  domains	  within	  the	  phylum,	  x	  =	  number	  of	  YbbR	  domains	  is	  less	  than	  half	  of	  the	  number	  of	  DAC	  domains	  within	  the	  phylum.	  **All	  phyla	  containing	  more	  than	  1	  DAC	  domain-­‐containing	  protein	  are	  listed	  with	  the	  number	  of	  DAC	  domains	  given	  in	  parenthesis.	  ***	  Abbreviations	  are	  as	  follows:	  DAC	  –	  diadenylate	  cyclase;	  PDE	  –	  phosphodiesterase;	  HhH	  –	  helix	  hairpin	  helix;	  PTS_EIIA_2	  -­‐	  phosphoenolpyruvate-­‐dependent	  sugar	  phosphotransferase	  system	  EIIA;	  TPR	  -­‐	  tetricopeptide	  repeat;	  PK_C	  -­‐	  pyruvate	  kinase	  C-­‐terminal	  alpha/beta	  C;	  PAS	  –	  Per	  Arnt	  Sim;	  PKD	  -­‐	  polycystic	  kidney	  disease	  I	  
